Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1952 5
1953 3
1959 1
1960 1
1961 1
1968 2
1969 1
1970 1
1971 1
1972 1
1973 2
1974 2
1975 1
1976 2
1977 5
1978 7
1979 5
1980 6
1981 10
1982 5
1983 7
1984 1
1985 5
1986 1
1987 7
1988 3
1989 8
1990 2
1991 10
1992 10
1993 4
1994 3
1995 6
1996 6
1997 5
1998 11
1999 5
2000 12
2001 13
2002 17
2003 11
2004 21
2005 15
2006 13
2007 30
2008 43
2009 43
2010 34
2011 48
2012 45
2013 57
2014 59
2015 48
2016 63
2017 78
2018 89
2019 96
2020 99
2021 89
2022 95
2023 79
2024 82
2025 103

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,384 results

Results by year

Filters applied: . Clear all
Page 1
Recurrence of IgA Nephropathy after Kidney Transplantation in Adults.
Uffing A, Pérez-Saéz MJ, Jouve T, Bugnazet M, Malvezzi P, Muhsin SA, Lafargue MC, Reindl-Schwaighofer R, Morlock A, Oberbauer R, Buxeda A, Burballa C, Pascual J, von Moos S, Seeger H, La Manna G, Comai G, Bini C, Russo LS, Farouk S, Nissaisorakarn P, Patel H, Agrawal N, Mastroianni-Kirsztajn G, Mansur J, Tedesco-Silva H, Ventura CG, Agena F, David-Neto E, Akalin E, Alani O, Mazzali M, Manfro RC, Bauer AC, Wang AX, Cheng XS, Schold JD, Berger SP, Cravedi P, Riella LV. Uffing A, et al. Among authors: russo ls. Clin J Am Soc Nephrol. 2021 Aug;16(8):1247-1255. doi: 10.2215/CJN.00910121. Clin J Am Soc Nephrol. 2021. PMID: 34362788 Free PMC article.
Zinc Fingers.
Isernia C, Malgieri G, Russo L, D'Abrosca G, Baglivo I, Pedone PV, Fattorusso R. Isernia C, et al. Among authors: russo l. Met Ions Life Sci. 2020 Mar 23;20:/books/9783110589757/9783110589757-018/9783110589757-018.xml. doi: 10.1515/9783110589757-018. Met Ions Life Sci. 2020. PMID: 32851833 Free article.
Glycans and diagnostics in nanomedicine.
Russo L. Russo L. Nanomedicine (Lond). 2021 Sep;16(21):1839-1842. doi: 10.2217/nnm-2021-0173. Epub 2021 Aug 5. Nanomedicine (Lond). 2021. PMID: 34348476 No abstract available.
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab.
Filho OM, Viale G, Stein S, Trippa L, Yardley DA, Mayer IA, Abramson VG, Arteaga CL, Spring LM, Waks AG, Wrabel E, DeMeo MK, Bardia A, Dell'Orto P, Russo L, King TA, Polyak K, Michor F, Winer EP, Krop IE. Filho OM, et al. Among authors: russo l. Cancer Discov. 2021 Oct;11(10):2474-2487. doi: 10.1158/2159-8290.CD-20-1557. Epub 2021 May 3. Cancer Discov. 2021. PMID: 33941592 Free PMC article. Clinical Trial.
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial.
Li Z, Metzger Filho O, Viale G, dell'Orto P, Russo L, Goyette MA, Kamat A, Yardley DA, Gupta Abramson V, Arteaga CL, Spring LM, Chiotti K, Halsey C, Waks AG, King TA, Lester SC, Bellon JR, Winer EP, Spellman PT, Krop IE, Polyak K. Li Z, et al. Among authors: russo l. J Clin Invest. 2024 Feb 1;134(7):e176454. doi: 10.1172/JCI176454. J Clin Invest. 2024. PMID: 38300710 Free PMC article. Clinical Trial.
Health Inequities in Pediatric Trauma.
Kayton ML, Staab V, Stahl B, Tan K, Russo L, Verney M, McGuire M, Pall H. Kayton ML, et al. Among authors: russo l. Children (Basel). 2023 Feb 9;10(2):343. doi: 10.3390/children10020343. Children (Basel). 2023. PMID: 36832472 Free PMC article. Review.
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT.
Tarantino P, Tayob N, Villacampa G, Dang C, Yardley DA, Isakoff SJ, Valero V, Faggen M, Mulvey T, Bose R, Weckstein D, Wolff AC, Reeder-Hayes K, Rugo HS, Ramaswamy B, Zuckerman D, Hart L, Gadi VK, Constantine M, Cheng K, Garrett AM, Marcom PK, Albain K, DeFusco P, Tung N, Ardman B, Nanda R, Jankowitz RC, Rimawi M, Abramson V, Pohlmann PR, Van Poznak C, Forero-Torres A, Liu MC, Ruddy KJ, Waks AG, DeMeo M, Burstein HJ, Partridge AH, Dell'Orto P, Russo L, Krause E, Newhouse DJ, Kurt BB, Mittendorf EA, Schneider B, Prat A, Winer EP, Krop IE, Tolaney SM; Consortium of the TBCRC Translational Investigators; TBCRC Translational Investigators. Tarantino P, et al. Among authors: russo l. J Clin Oncol. 2024 Nov;42(31):3652-3665. doi: 10.1200/JCO.23.02170. Epub 2024 Jun 27. J Clin Oncol. 2024. PMID: 38935923 Free PMC article. Clinical Trial.
1,384 results